The provider images a wide area including the lower portion of the liver and spleen and the entire abdomen and pelvic region after administering a radiopharmaceutical or tracer. The goal is to identify where the patient is bleeding from when there is no direct evidence of active bleeding in the lower gastrointestinal tract or when active bleeding prevents adequate visualization of the bowel.
For clinical responsibility, terminology, tips and additional info
start codify free trial.